Brookstone Capital Management Bio Techne Corp Transaction History

Brookstone Capital Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$189.68 - $222.09 $225,529 - $264,065	-1,189 Closed	0 $0
Q3 2019 Oct 18, 2019	SELL	$183.56 - $216.72 $187,231 - $221,054	-1,020 Reduced 46.17%	1,189 $233,000
Q2 2019 Jul 25, 2019	SELL	$188.72 - $215.43 $76,997 - $87,895	-408 Reduced 15.59%	2,209 $461,000
Q1 2019 Apr 18, 2019	BUY	$136.09 - $200.44 $356,147 - $524,551	2,617 New	2,617 $520,000
Q4 2018 Feb 06, 2019	SELL	$132.75 - $203.8 $396,258 - $608,343	-2,985 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$147.44 - $204.11 $57,943 - $80,215	-393 Reduced 11.63%	2,985 $609,000
Q2 2018 Aug 06, 2018	BUY	$144.9 - $165.58 $61,727 - $70,537	426 Added 14.43%	3,378 $500,000
Q1 2018 Apr 23, 2018	BUY	$131.46 - $151.04 $26,554 - $30,510	202 Added 7.35%	2,952 $446,000
Q4 2017 Feb 07, 2018	SELL	$121.17 - $134.75 $3,635 - $4,042	-30 Reduced 1.08%	2,750 $356,000
Q3 2017 Oct 31, 2017	BUY	$113.59 - $123.78 $31,010 - $33,791	273 Added 10.89%	2,780 $336,000
Q2 2017 Aug 08, 2017	BUY	N/A	2,507	2,507 $295,000

616

156M

200K

15.3K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.59B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

Stay updated on Brookstone Capital Management with notifications on news.